Sprache: Englisch
Verlag: Cambridge University Press, 2007
ISBN 10: 0521030749 ISBN 13: 9780521030748
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 81,28
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 2007
ISBN 10: 0521030749 ISBN 13: 9780521030748
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2008. New Ed. Paperback. International authorities review the mechanisms and clinical implications of drug resistance in cancer. Series: Cancer: Clinical Science in Practice. Num Pages: 340 pages, 35 b/w illus. 32 tables. BIC Classification: MJCL2. Category: (P) Professional & Vocational. Dimension: 228 x 152 x 19. Weight in Grams: 500. . . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Cambridge University Press, 2006
ISBN 10: 0521030749 ISBN 13: 9780521030748
Anbieter: moluna, Greven, Deutschland
Zustand: New. Reviews the mechanisms and clinical implications of drug resistance in cancer, considered to be the most significant obstacle to the cure of cancer today. Topics covered include multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose.
Sprache: Englisch
Verlag: Cambridge University Press, 2007
ISBN 10: 0521030749 ISBN 13: 9780521030748
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumours that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the course of their treatment. This book reviews the mechanisms and clinical implications of drug resistance in cancer with unrivalled authority. Chapters cover topics of current clinical concern, including multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support. The authors are among the leading clinicians and investigators in the field. These authoritative volumes in this series are intended for a wide audience of clinicians and researchers with an interest in the applications of biomedical science to the understanding and management of cancer.